Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib.

MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib. AJR Am J Roentgenol. 2013 Jan; 200(1):120-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.